These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 19782387

  • 1. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE, Almodovar R, Carmona L, Carreira PE.
    Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
    [Abstract] [Full Text] [Related]

  • 2. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF, Pope JE, Ouimet JM.
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [Abstract] [Full Text] [Related]

  • 3. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
    Czirják L, Kumánovics G, Varjú C, Nagy Z, Pákozdi A, Szekanecz Z, Szucs G.
    Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
    Foocharoen C, Nanagara R, Kiatchoosakun S, Suwannaroj S, Mahakkanukrauh A.
    Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
    [Abstract] [Full Text] [Related]

  • 5. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P.
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [Abstract] [Full Text] [Related]

  • 6. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA.
    Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
    [Abstract] [Full Text] [Related]

  • 7. [Causes of death of patients with systemic sclerosis].
    Chwieśko S, Sierakowski S, Kowal-Bielecka O.
    Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
    [Abstract] [Full Text] [Related]

  • 8. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.
    Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R.
    J Med Assoc Thai; 2002 Nov; 85(11):1204-9. PubMed ID: 12546318
    [Abstract] [Full Text] [Related]

  • 9. Changes in causes of death in systemic sclerosis, 1972-2002.
    Steen VD, Medsger TA.
    Ann Rheum Dis; 2007 Jul; 66(7):940-4. PubMed ID: 17329309
    [Abstract] [Full Text] [Related]

  • 10. Mortality in systemic sclerosis (scleroderma).
    Lee P, Langevitz P, Alderdice CA, Aubrey M, Baer PA, Baron M, Buskila D, Dutz JP, Khostanteen I, Piper S.
    Q J Med; 1992 Feb; 82(298):139-48. PubMed ID: 1620814
    [Abstract] [Full Text] [Related]

  • 11. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [Abstract] [Full Text] [Related]

  • 12. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
    Teixeira L, Mouthon L, Mahr A, Berezné A, Agard C, Mehrenberger M, Noël LH, Trolliet P, Frances C, Cabane J, Guillevin L, Group Français de Recherche sur le Sclérodermie (GFRS).
    Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
    [Abstract] [Full Text] [Related]

  • 13. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A, Bartosik I, Wuttge DM, Hesselstrand R.
    Scand J Rheumatol; 2009 Jan; 38(4):295-8. PubMed ID: 19214870
    [Abstract] [Full Text] [Related]

  • 14. Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.
    Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio AP, Samara AM, Yoshinari NH, Marques-Neto JF.
    J Rheumatol; 2012 Oct; 39(10):1971-8. PubMed ID: 22896025
    [Abstract] [Full Text] [Related]

  • 15. Survival, mortality and causes of death in inflammatory myopathies.
    Torres C, Belmonte R, Carmona L, Gómez-Reino FJ, Galindo M, Ramos B, Cabello A, Carreira PE.
    Autoimmunity; 2006 May; 39(3):205-15. PubMed ID: 16769654
    [Abstract] [Full Text] [Related]

  • 16. Mortality in systemic sclerosis: an international meta-analysis of individual patient data.
    Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM.
    Am J Med; 2005 Jan; 118(1):2-10. PubMed ID: 15639201
    [Abstract] [Full Text] [Related]

  • 17. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.
    Fransen J, Popa-Diaconu D, Hesselstrand R, Carreira P, Valentini G, Beretta L, Airo P, Inanc M, Ullman S, Balbir-Gurman A, Sierakowski S, Allanore Y, Czirjak L, Riccieri V, Giacomelli R, Gabrielli A, Riemekasten G, Matucci-Cerinic M, Farge D, Hunzelmann N, Van den Hoogen FH, Vonk MC.
    Ann Rheum Dis; 2011 Oct; 70(10):1788-92. PubMed ID: 21784727
    [Abstract] [Full Text] [Related]

  • 18. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD, Medsger TA.
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [Abstract] [Full Text] [Related]

  • 19. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP.
    QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
    [Abstract] [Full Text] [Related]

  • 20. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
    Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, Tohma S, Endo H, Hirohata S.
    J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.